KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Total Liabilities (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Total Liabilities for 17 consecutive years, with $71.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 6.14% to $71.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $71.5 billion, a 6.14% decrease, with the full-year FY2025 number at $71.5 billion, down 6.14% from a year prior.
  • Total Liabilities was $71.5 billion for Q4 2025 at Bristol Myers Squibb, up from -$18.6 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $137.3 billion in Q3 2024 to a low of -$18.6 billion in Q3 2025.
  • A 5-year average of $66.0 billion and a median of $73.5 billion in 2021 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: surged 76749.12% in 2024, then tumbled 113.51% in 2025.
  • Bristol Myers Squibb's Total Liabilities stood at $73.3 billion in 2021, then decreased by 10.38% to $65.7 billion in 2022, then decreased by 0.04% to $65.7 billion in 2023, then grew by 16.05% to $76.2 billion in 2024, then decreased by 6.14% to $71.5 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Total Liabilities are $71.5 billion (Q4 2025), -$18.6 billion (Q3 2025), and $77.2 billion (Q2 2025).